Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report
Sign Up to like & getrecommendations! Published in 2020 at "BMC Neurology"
DOI: 10.1186/s12883-020-01813-1
Abstract: Background The onset of myasthenia (MG) gravis with anti-muscle-specific tyrosine kinase (MuSK) antibodies most commonly peaks in the fourth decade of life, and MG with MuSK antibodies (MuSK-MG) rarely coexists with a malignant tumor. To… read more here.
Keywords: anti muscle; gravis anti; case; myasthenia gravis ... See more keywords